313 related articles for article (PubMed ID: 16399567)
1. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.
Shulman HM; Kleiner D; Lee SJ; Morton T; Pavletic SZ; Farmer E; Moresi JM; Greenson J; Janin A; Martin PJ; McDonald G; Flowers ME; Turner M; Atkinson J; Lefkowitch J; Washington MK; Prieto VG; Kim SK; Argenyi Z; Diwan AH; Rashid A; Hiatt K; Couriel D; Schultz K; Hymes S; Vogelsang GB
Biol Blood Marrow Transplant; 2006 Jan; 12(1):31-47. PubMed ID: 16399567
[TBL] [Abstract][Full Text] [Related]
2. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
Filipovich AH; Weisdorf D; Pavletic S; Socie G; Wingard JR; Lee SJ; Martin P; Chien J; Przepiorka D; Couriel D; Cowen EW; Dinndorf P; Farrell A; Hartzman R; Henslee-Downey J; Jacobsohn D; McDonald G; Mittleman B; Rizzo JD; Robinson M; Schubert M; Schultz K; Shulman H; Turner M; Vogelsang G; Flowers ME
Biol Blood Marrow Transplant; 2005 Dec; 11(12):945-56. PubMed ID: 16338616
[TBL] [Abstract][Full Text] [Related]
3. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.
Pavletic SZ; Lee SJ; Socie G; Vogelsang G
Bone Marrow Transplant; 2006 Nov; 38(10):645-51. PubMed ID: 16980994
[TBL] [Abstract][Full Text] [Related]
4. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.
Pavletic SZ; Martin P; Lee SJ; Mitchell S; Jacobsohn D; Cowen EW; Turner ML; Akpek G; Gilman A; McDonald G; Schubert M; Berger A; Bross P; Chien JW; Couriel D; Dunn JP; Fall-Dickson J; Farrell A; Flowers ME; Greinix H; Hirschfeld S; Gerber L; Kim S; Knobler R; Lachenbruch PA; Miller FW; Mittleman B; Papadopoulos E; Parsons SK; Przepiorka D; Robinson M; Ward M; Reeve B; Rider LG; Shulman H; Schultz KR; Weisdorf D; Vogelsang GB;
Biol Blood Marrow Transplant; 2006 Mar; 12(3):252-66. PubMed ID: 16503494
[TBL] [Abstract][Full Text] [Related]
5. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.
Hillen U; Häusermann P; Massi D; Janin A; Wolff D; Lawitschka A; Greinix H; Meyer R; Ziemer M
J Eur Acad Dermatol Venereol; 2015 May; 29(5):948-54. PubMed ID: 25265987
[TBL] [Abstract][Full Text] [Related]
6. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
7. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.
Carpenter PA; Kitko CL; Elad S; Flowers ME; Gea-Banacloche JC; Halter JP; Hoodin F; Johnston L; Lawitschka A; McDonald GB; Opipari AW; Savani BN; Schultz KR; Smith SR; Syrjala KL; Treister N; Vogelsang GB; Williams KM; Pavletic SZ; Martin PJ; Lee SJ; Couriel DR
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1167-87. PubMed ID: 25838185
[TBL] [Abstract][Full Text] [Related]
8. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.
Martin PJ; Weisdorf D; Przepiorka D; Hirschfeld S; Farrell A; Rizzo JD; Foley R; Socie G; Carter S; Couriel D; Schultz KR; Flowers ME; Filipovich AH; Saliba R; Vogelsang GB; Pavletic SZ; Lee SJ;
Biol Blood Marrow Transplant; 2006 May; 12(5):491-505. PubMed ID: 16635784
[TBL] [Abstract][Full Text] [Related]
9. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.
Lee SJ; Wolff D; Kitko C; Koreth J; Inamoto Y; Jagasia M; Pidala J; Olivieri A; Martin PJ; Przepiorka D; Pusic I; Dignan F; Mitchell SA; Lawitschka A; Jacobsohn D; Hall AM; Flowers ME; Schultz KR; Vogelsang G; Pavletic S
Biol Blood Marrow Transplant; 2015 Jun; 21(6):984-99. PubMed ID: 25796139
[TBL] [Abstract][Full Text] [Related]
10. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
Schultz KR; Miklos DB; Fowler D; Cooke K; Shizuru J; Zorn E; Holler E; Ferrara J; Shulman H; Lee SJ; Martin P; Filipovich AH; Flowers ME; Weisdorf D; Couriel D; Lachenbruch PA; Mittleman B; Vogelsang GB; Pavletic SZ
Biol Blood Marrow Transplant; 2006 Feb; 12(2):126-37. PubMed ID: 16443511
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.
Greinix HT; Loddenkemper C; Pavletic SZ; Holler E; Socié G; Lawitschka A; Halter J; Wolff D
Biol Blood Marrow Transplant; 2011 Feb; 17(2):167-75. PubMed ID: 20691801
[TBL] [Abstract][Full Text] [Related]
12. NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.
Shulman HM; Cardona DM; Greenson JK; Hingorani S; Horn T; Huber E; Kreft A; Longerich T; Morton T; Myerson D; Prieto VG; Rosenberg A; Treister N; Washington K; Ziemer M; Pavletic SZ; Lee SJ; Flowers ME; Schultz KR; Jagasia M; Martin PJ; Vogelsang GB; Kleiner DE
Biol Blood Marrow Transplant; 2015 Apr; 21(4):589-603. PubMed ID: 25639770
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
[TBL] [Abstract][Full Text] [Related]
14. The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification.
Socié G
Leukemia; 2009 Jan; 23(1):1-2. PubMed ID: 19142188
[No Abstract] [Full Text] [Related]
15. [Skin biopsy in diagnosis of chronic graft-versus-host disease in patients after allogeneic haematopoietic stem cell transplantation: pathologist's point of view on quantitative scoring system].
Grzanka D; Styczyński J; Debski R; Krenska A; Pacholska M; Prokurat AI; Wysocki M; Marszałek A
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1105-11. PubMed ID: 19531834
[TBL] [Abstract][Full Text] [Related]
16. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
Jagasia MH; Greinix HT; Arora M; Williams KM; Wolff D; Cowen EW; Palmer J; Weisdorf D; Treister NS; Cheng GS; Kerr H; Stratton P; Duarte RF; McDonald GB; Inamoto Y; Vigorito A; Arai S; Datiles MB; Jacobsohn D; Heller T; Kitko CL; Mitchell SA; Martin PJ; Shulman H; Wu RS; Cutler CS; Vogelsang GB; Lee SJ; Pavletic SZ; Flowers ME
Biol Blood Marrow Transplant; 2015 Mar; 21(3):389-401.e1. PubMed ID: 25529383
[TBL] [Abstract][Full Text] [Related]
17. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.
Paczesny S; Hakim FT; Pidala J; Cooke KR; Lathrop J; Griffith LM; Hansen J; Jagasia M; Miklos D; Pavletic S; Parkman R; Russek-Cohen E; Flowers ME; Lee S; Martin P; Vogelsang G; Walton M; Schultz KR
Biol Blood Marrow Transplant; 2015 May; 21(5):780-92. PubMed ID: 25644957
[TBL] [Abstract][Full Text] [Related]
18. [2018 update on chronic graft-versus-host disease].
Inamoto Y
Rinsho Ketsueki; 2018; 59(10):2300-2306. PubMed ID: 30305539
[TBL] [Abstract][Full Text] [Related]
19. Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease.
Cardona DM; Detweiler CJ; Shealy MJ; Sung AD; Wild DM; Poleski MH; Balmadrid BL; Cirrincione CT; Howell DN; Sullivan KM
Arch Pathol Lab Med; 2018 Sep; 142(9):1098-1105. PubMed ID: 29697275
[TBL] [Abstract][Full Text] [Related]
20. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
